Influenza A: New Therapeutic Targets for a Deadly Disease.
作者信息
Manzano Diego, Izquierdo-Garcia José L, Martín-Loeches Ignacio, Lorente José A
机构信息
Hospital Universitario de Getafe, Madrid, Spain.
CIC biomaGUNE, Donostia-San Sebastian, Spain; CIBER de Enfermedades Respiratorias, Spain.
出版信息
Arch Bronconeumol (Engl Ed). 2019 Jun;55(6):295-296. doi: 10.1016/j.arbres.2018.09.020. Epub 2018 Nov 5.
PMID:30409486
Abstract
摘要
相似文献
1
Influenza A: New Therapeutic Targets for a Deadly Disease.甲型流感：一种致命疾病的新治疗靶点
Arch Bronconeumol (Engl Ed). 2019 Jun;55(6):295-296. doi: 10.1016/j.arbres.2018.09.020. Epub 2018 Nov 5.
2
[Problems of the molecular mechanism of the effects of synthetic antiviral drugs].
Antibiot Khimioter. 1989 Sep;34(9):652-6.
3
[Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].[帕拉米韦。一种用于治疗流感的新型强效神经氨酸酶抑制剂]
Rev Esp Quimioter. 2006 Dec;19(4):317-22.
4
[Synthesis of virus-specific RNA in influenza virus-infected cells in the presence of bonafton].[在存在波那芬的情况下流感病毒感染细胞中病毒特异性RNA的合成]
Farmakol Toksikol. 1985 Jul-Aug;48(4):92-5.
5
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.干扰病毒-宿主细胞相互作用和细胞信号通路作为抗流感病毒感染的一种方法。
Biol Chem. 2011 Oct;392(10):837-47. doi: 10.1515/BC.2011.121.
6
Baloxavir marboxil: the new influenza drug on the market.巴洛沙韦玛波西利：市场上的新型流感药物。
Curr Opin Virol. 2019 Apr;35:14-18. doi: 10.1016/j.coviro.2019.01.006. Epub 2019 Mar 8.
7
[Development of anti-influenza drug].[抗流感药物的研发]
Bing Du Xue Bao. 2011 Sep;27(5):475-80.
8
Inhibition of influenza virus replication by plant-derived isoquercetin.植物源异槲皮苷抑制流感病毒复制。
Antiviral Res. 2010 Nov;88(2):227-35. doi: 10.1016/j.antiviral.2010.08.016. Epub 2010 Sep 6.
9
The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment.宿主体内流感病毒控制机制影响基于模型的抗病毒治疗评估与预测。
Viruses. 2017 Jul 26;9(8):197. doi: 10.3390/v9080197.
10
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.VX-787的临床前活性，一种一流的、口服生物可利用的流感病毒聚合酶PB2亚基抑制剂。
Antimicrob Agents Chemother. 2015 Mar;59(3):1569-82. doi: 10.1128/AAC.04623-14. Epub 2014 Dec 29.
Zotero 插件